ارتفاع الضغط داخل المقلة(I. O .P) بعد حقن التريامسينولون اسيتونيد تحت التينون
Abstract
الهدف: دراسة حدوث ارتفاع I.O.P بعد حقن تريامسينولون تحت التينون الطرق : تمت الدراسة على 40 مريض 50 عيناً تلقوا 40 مغ تريامسينولون تحت التينون لعلاج أمراض مختلفة تمت مراقبة الضغط داخل المقلة و تحديد العيون التي ارتفع فيها الضغط ≥ 5 ملمز و ذروة I.O.P و العلاقة بين I.O.P و العمر و الجنس و نوع المرض وعدد الحقن النتائج : I.O.P≥ 5 ملمز وجد في 25 عيناً أي 50% من العيون المدروسة بدأ ارتفاع I.O.P بشكل هام بعد شهر من الحقن( 20% ) وصل إلى الذروة بعد 3 أشهر ( 80 % ) و عاد إلى المستوى الأساسي قبل الحقن بعد 10 أشهر يزداد I.O.P عند الشباب 80 % بالأعمار بين 40– 50 سنة وعند الإناث >الذكور ( 59,09% و 42,8%) على التوالي, وبالحقنة الوحيدة أقل من الحقن المتعددة ( 47,3% و 60%)على التوالي لا يوجد علاقة هامة بين نوع المرض المعالج و حقن التريامسينولون تحت التينون الاستنتاج: تعدد الحقن و الأعمار الشابة و خصوصاً بين النساء يزيد نسبة حدوث ارتفاع I.O.P بعد حقن التريامسينولون تحت التينون Purpose : to determine the incidence of eyes that have an increase in the intraocular pressure( I.O.P ) after subtenon injection of triamcinolone acetonide . Methods: 40 patient 50 eyes treated with 40 mg subtenon injection of TA for different diseases. The incidence of an I.O.P elevation ≥ 5mmhg was determine, the peak of I.O.P, the relation between I.O.P elevation and the age, gender, the kind of disease and the number of we injections of ta Results : an elevation I.O.P≥ 5mmhg was found in 25 eyes ( 50%) . The I.O.P began to increase significantly from 1 month (20%) The peak of I.O.P after 3 months (80%) and returned to the baseline I.O.P in 10 months . the elevation I.O.P≥ 5 mmhg was significantly related with younger age (80%) between 40-50 years the elevation I.O.P is between females' more in cedence than males (59,59%) females and (42,8%) males, and is less incidence aftere single injection (42.8%) less than multi injection (60%) multiple No significant relation is round between the disease and the incidence of increased I.O.P . Conclusion : repeated injections of TA and injection of younger patients especially women increase the incidence of an I.O.P elevation .Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.